Severe acute respiratory syndrome vs. the Middle East respiratory syndrome
- PMID: 24626235
- DOI: 10.1097/MCP.0000000000000046
Severe acute respiratory syndrome vs. the Middle East respiratory syndrome
Abstract
Purpose of review: This review compares the clinical features, laboratory aspects and treatment options of severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS).
Recent findings: Bats are the natural reservoirs of SARS-like coronaviruses (CoVs) and are likely the reservoir of MERS coronavirus (MERS-CoV). Although a small number of camels have been found to have positive nasal swabs by real-time polymerase chain reaction and to carry antibody against MERS-CoV, the transmission route and the intermediary animal source remain uncertain amongst the sporadic primary cases. Both SARS-CoV and MERS-CoV may cause severe respiratory failure and extrapulmonary features such as diarrhoea, whereas mild or asymptomatic cases also occur in both conditions. In comparison with SARS, patients with MERS are older with male predominance, more comorbid illness and relatively lower human-to-human transmission potential. Although the viral kinetics of MERS-CoV remain unknown, nosocomial infections of MERS occur early within the first week of illness of the index case, whereas those of SARS occurred mainly in the second week of illness when the patient's upper airway viral load peaks on day 10 of illness. In-vitro data suggest that interferon (IFN) with or without ribavirin and mycophenolic acid may inhibit MERS-CoV, whereas protease inhibitors and IFN have inhibitory activity against SARS-CoV.
Summary: Although there are some similarities in the clinical features, MERS progresses to respiratory failure much more rapidly than SARS. The higher case fatality rate of MERS is likely related to older age and comorbid illness. More studies are needed to understand MERS-CoV in order to guide public health infection control measures and treatment.
Similar articles
-
Epidemic and Emerging Coronaviruses (Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome).Clin Chest Med. 2017 Mar;38(1):71-86. doi: 10.1016/j.ccm.2016.11.007. Epub 2016 Dec 16. Clin Chest Med. 2017. PMID: 28159163 Free PMC article. Review.
-
[Etiological, epidemiological and clinical aspects of coronavirus infection MERS-CoV].Pol Merkur Lekarski. 2015 Jan;38(223):46-50. Pol Merkur Lekarski. 2015. PMID: 25763589 Review. Polish.
-
Ribavirin and interferon-α2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases.Antivir Ther. 2015;20(1):87-91. doi: 10.3851/IMP2792. Epub 2014 May 15. Antivir Ther. 2015. PMID: 24831606
-
Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection.Ann Intern Med. 2014 Mar 18;160(6):389-97. doi: 10.7326/M13-2486. Ann Intern Med. 2014. PMID: 24474051
-
Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment.J Gen Virol. 2013 Dec;94(Pt 12):2679-2690. doi: 10.1099/vir.0.055533-0. Epub 2013 Sep 28. J Gen Virol. 2013. PMID: 24077366
Cited by
-
Nigella sativa and its chemical constituents: pre-clinical and clinical evidence for their potential anti-SARS-CoV-2 effects.Inflammopharmacology. 2024 Feb;32(1):273-285. doi: 10.1007/s10787-023-01385-9. Epub 2023 Nov 15. Inflammopharmacology. 2024. PMID: 37966624 Review.
-
Improved performance of nucleic acid-based assays for genetically diverse norovirus surveillance.Appl Environ Microbiol. 2023 Oct 31;89(10):e0033123. doi: 10.1128/aem.00331-23. Epub 2023 Oct 4. Appl Environ Microbiol. 2023. PMID: 37791775 Free PMC article.
-
COVID-19 induces gastrointestinal symptoms and affects patients' prognosis.J Int Med Res. 2022 Oct;50(10):3000605221129543. doi: 10.1177/03000605221129543. J Int Med Res. 2022. PMID: 36238995 Free PMC article. Review.
-
New endemic and pandemic pathologies with interhuman airborne transmission through ear, nose and throat anatomical sites.Acta Otorhinolaryngol Ital. 2022 Apr;42(Suppl. 1):S5-S13. doi: 10.14639/0392-100X-suppl.1-42-2022-01. Acta Otorhinolaryngol Ital. 2022. PMID: 35763270 Free PMC article.
-
Comparative overview of emerging RNA viruses: Epidemiology, pathogenesis, diagnosis and current treatment.Ann Med Surg (Lond). 2022 Jul;79:103985. doi: 10.1016/j.amsu.2022.103985. Epub 2022 Jun 11. Ann Med Surg (Lond). 2022. PMID: 35721786 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous